Why GM stock is getting hit the hardest by Trump auto tariffs

Why GM stock is getting hit the hardest by Trump auto tariffs


The GM logo is seen on a water tank of the General Motors assembly plant in Ramos Arizpe, in Coahuila state, Mexico, on Feb. 11, 2021.

Daniel Becerril | Reuters

As auto stocks reacted to the latest tariff announcement out of Washington, D.C., on Thursday, General Motors took the brunt of the hit.

Shares of GM were down more than 6% in mid-morning trading, far underperforming the likes of Ford and Stellantis, which shed about 2% and 1%, respectively. Tesla stock was up about more than 5%.

The divergence stems from the amount of vehicles that GM imports, and its exposure to Mexico in particular.

“Tesla and Ford appear to be the most shielded given location of vehicle assembly facilities although Ford does face incremental exposure on imported engines,” Deutsche Bank analysts wrote in a note Thursday. “GM has the most exposure to Mexico.”

President Donald Trump on Wednesday announced his administration would impose 25% tariffs on “all cars that are not made in the United States” and some automobile parts. The executive order signed Wednesday allows for some leniency for components that are compliant with the United States-Mexico-Canada Agreement, but it was not immediately clear what relief that might offer the North American automotive industry.

Stock Chart IconStock chart icon

hide content

General Motors stock falls after Trump tariff announcement.

Mexico accounted for 16.2% of vehicle imports into the U.S. as a percentage of sales in 2024, according to GlobalData. That was the largest share of any country, about double the shares of South Korea and Japan, which ranked second and third in terms of import volume, respectively.

Roughly 52% of GM vehicles sold in the U.S. during the first three quarters of 2024 were assembled in the U.S., according to research by Barclays analyst Dan Levy. That leaves 30% assembled in Canada and Mexico, and another 18% brought in from other countries.

Levy also pointed out that GM relies heavily on Mexico and South Korea for production of some of its small crossovers, including its Equinox and Blazer vehicles.

“Roughly half of GM’s US sales are produced in the US, but imported parts are a concern,” he said.

During the same period, 57% of Stellantis vehicles and 78% of Ford vehicles sold in the U.S. were assembled stateside. Levy reported Stellantis assembled 39% of its U.S.-sold units in Canada and Mexico, and Ford, just 21%.

Wolfe Research’s Emmanuel Rosner said the tariffs primarily affect foreign-brand automakers, but noted that 15% of GM’s U.S. vehicles come from South Korea.

John Murphy from Bank of America said in comparison to the broader automotive market, GM is “relatively exposed to the tariffs” and may need to rebalance.

GM stock is down 13% year to date. Shares fell sharply in late January after investors worried that the automaker did not address concerns about tariffs in its most recent earnings report.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More